A trial involving roughly 1,500 patients found that those who took an inexpensive drug called fluvoxamine were significantly less likely to progress to severe COVID-19 disease and require hospitalization, according to the
Associated Press.
| | |
| The Latest on COVID-19 | | | Updated on October 28, 2021 at 1:45 p.m. PDT | - A trial involving roughly 1,500 patients found that those who took an inexpensive drug called fluvoxamine were significantly less likely to progress to severe COVID-19 disease and require hospitalization, according to the Associated Press.
- The World Health Organization (WHO) is closely tracking the Delta Plus AY.4.2 subvariant of COVID-19 to determine whether it is more infectious. According to the weekly epidemiological update from the WHO, they also want to determine whether this subvariant is significantly more resistant to human antibodies that fight the virus.
- The Oakland Unified school board has approved a plan that mandates that students must be vaccinated against COVID-19 to attend in-person classes, according to Oaklandside. Students over age 12 will have until January 1 to get vaccinated or to enroll in an independent study program.
| | Researchers found that the number of people who were put on a liver transplant waiting list or who got a liver transplant due to alcoholic hepatitis was 50 percent higher than what was expected based... | | | Advertisement |  | | Healthy meal prep, simplified with Green Chef | | | Menu variety for plant-powered choices, balanced living, keto, and paleo diets. GET STARTED  | |  | | Advertisement | | Healthy meal prep, simplified with Green Chef | | | | Menu variety for plant-powered choices, balanced living, keto, and paleo diets. | | | | | |
No comments:
Post a Comment
Keep a civil tongue.